NewsRx

Search our medical news database

Menopause

Estrogen patch compared with pill minimizes cardiovascular risk factor

Published in Women's Health Weekly, May 8th, 2003

Administering estrogen replacement therapy via a skin patch rather than a pill minimizes a cardiovascular risk factor in postmenopausal women, according to researchers at UT Southwestern Medical Center at Dallas.

Recent studies have suggested that oral estrogen replacement therapy and combined hormone replacement therapy resulted in an increase in C-reactive protein (CRP). CRP is a marker for inflammation in the blood vessels and is the strongest independent predictor of adverse cardiovascular events in otherwise healthy postmenopausal women.

In findings reported in the Journal of the American College of Cardiology, researchers at UT...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook